Day: ខែ​ឧសភា 30, 2025

‘ASIA CONNECT: DUBAI’ DISCUSSES OPPORTUNITIES FOR ASIAN REAL ESTATE INVESTMENT IN THE LEAD UP TO THE SECOND EDITION OF THE AWARDS IN THE MIDDLE EASTDUBAI, May 30, 2025 – (ACN Newswire via SeaPRwire.com) – PropertyGuru, Southeast Asia’s leading property technology company, today launched the latest edition of its real estate awards programme in the Middle East from Dubai, expanding its reach into the region’s thriving markets.Following a successful debut in 2024, the PropertyGuru Asia Property Awards (Middle East) return for their second edition, providing a widely respected, trusted platform for showcasing the achievements and innovations of developers in the region.The PropertyGuru Asia Property Awards (Middle East) return for their second edition with the inaugural “Asia Connect: Dubai” launch eventThe timeline for the 2025 awards season was revealed today during the “Asia Connect: Dubai” event at the Conrad Dubai Hotel, with distinguished guests and organisers in attendance. The 2025 PropertyGuru Asia Prop…

HONG KONG, May 29, 2025 – (ACN Newswire via SeaPRwire.com) – MODONG Coffee, a leading global health and wellness brand, is proud to announce its sponsorship of G-DRAGON 2025 WORLD TOUR [Übermensch] IN TAIPEI, presented by KGI FINANCIAL GROUP, taking place on July 11 (Fri.) and July 13 (Sun.) at the Taipei Arena. As the Official Sponsor, MODONG Coffee brings an innovative fusion of “Music × MODONG Energy” to create an immersive audiovisual experience for fans. This collaboration marks a strategic milestone in MODONG Coffee’s youth-centric expansion, advancing its “IP + Scenarios + New Retail” ecosystem.As one of Asia’s most influential music IPs, G-DRAGON’s upcoming tour, themed “Übermensch”, symbolizes his groundbreaking interpretation of art and self-expression. As an Official Sponsor, MODONG Coffee joins forces with Samsung, ADATA Technology, and other brands to deliver an immersive experience, seamlessly blending stunning visuals with exceptional music for the audience. As the flagship product of Star Plus…

Key Highlights- Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy- Globally, this is the first bispecific CD19-directed CD3 T cell engager immunotherapy for this autoimmune disease- Milder T cell activation than Blincyto and Target cell-dependent T cell activation- Multiple CR cases observed in ongoing r/r NHL Phase Ia trial and r/r ALL Phase Ib/II trialHONG KONG, May 29, 2025 – (ACN Newswire via SeaPRwire.com) – Excyte, a global clinical-stage biotechnology company, announced first patient has been dosed for YK012, the world’s first patient T cell engager that entered into clinical trial for primary membranous nephropathy (pMN). The patient remained well after administration with no adverse reactions witnessed to date.pMN is an autoimmune disease caused by the attack of autoantibodies against podocyte antigens leading to the in situ production of immune complexes. pMN is the most common cause of primary nephrotic syndrome in non-diabetic adults worldwide, accountin…

Key Financial Performance Highlights for Q3FY2025:Group’s total revenue for the quarter jumps to RM75.1 million, with e-mobility and energy storage segments as primary contributors, followed by electronicsPerformance for the quarter supported by prompt execution of outstanding orders from FY2024 and progress on new scopes secured within existing client baseBoth PBT and PAT stand at RM3.2 million for the quarter under reviewGP, PBT, PAT, and PATAMI margins recorded at 11.6%, 4.3%, 4.3% and 1.1% respectivelyBANGI, Malaysia, May 29, 2025 – (ACN Newswire via SeaPRwire.com) – Technology leader in providing turnkey, intelligent manufacturing automation solutions, GENETEC TECHNOLOGY BERHAD (“Genetec” or the “Company”), today announced its financial results for the third quarter ended 31 March 2025 (“Q3FY2025”). The Company reported a jump in their revenue to RM75.1 million, on par with the preceding year-on-year revenue levels, supported by the delivery of outstanding and new orders across its core client base. Gros…

WILMINGTON, DE, May 29, 2025 – (ACN Newswire via SeaPRwire.com) – Naoris Protocol, the first quantum-resistant blockchain and cybersecurity mesh architecture, has raised $3 million in a strategic funding round led by Mason Labs, that includes Frekaz Group, Level One Robotics and Tradecraft Capital following a six-month technical due diligence process.The round, which includes proceeds from Naoris’s public sale and related allocations, was oversubscribed, prompting the team to open a new institutional raise — now live as of today, Thursday, 29 May.David Carvalho, CEO and Founder of Naoris Protocol, says: “The strong interest we’ve seen from institutions reflects how urgently the industry is beginning to take the threat of quantum computing seriously. This investment supports our mission to future-proof the blockchain ecosystem before these risks become reality.”Mason Labs, a leading venture capital firm focused on infrastructure-grade technologies, conducted a detailed review of Naoris Protocol’s post-quantum …